BrainStorm Cell Therapeutics Inc. (BCLI) previously at $0.77 up 19% at $0.92 with 370
 

BrainStorm Cell Therapeutics Inc. (BCLI) previously at $0.77 up 19% at $0.92 with 370,797 shares traded (BCLI) was highlighted today by OTC Picks

BrainStorm Cell Therapeutics Inc. announced this month that they have hired 5W Public Relations as its PR agency of record. Both companies hope to raise awareness of neurological disorders such as Parkinson's, Amyotrophic Lateral Sclerosis and Multiple Sclerosis. BrainStorm Cell Therapeutics Inc. utilizes cutting edge, non-controversial stem cell research cultivating adult stem cells rather than embryonic tissue. BrainStorm's goal is to develop long-term and even permanent remedies for these life-threatening disorders.

BrainStorm Cell Therapeutics Inc. is an emerging company developing adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of neurodegenerative diseases.
http://www.transworldnews.com/NewsSt...t=Default.aspx